Treatment of ophthalmic diseases
AssigneeAmMax Bio, Inc.
InventorsKirk William JOHNSON, Laman ALANI
Life of this patent
Estimating the term…
Abstract
Provided herein are pharmaceutical compositions and related methods for treating ophthalmic diseases. The method entails administering to the patient an effective amount of a CSF1R inhibitor, such as an anti-CSF1R antibody. The methods are effective in reducing vascular hyperpermeability, neovascularization and fibrosis such as macular fibrosis. Combination therapies that also include a VEGF inhibitor are also provided. Preferably, the administration is via intravitreal injection.
Claims19
A method for treating an ophthalmic disease in a human patient in need thereof, comprising administering to the patient an effective amount of a CSF1R inhibitor.
Dependencies are inferred from the claim text.